Theriva Biologics, Inc. Deferred Tax Liabilities, Gross
Theriva Biologics, Inc. (TOVX) had Deferred Tax Liabilities, Gross of $5.45 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-12
- 2025-12-31: Deferred Tax Liabilities, Gross $5.45M.
- 2024-12-31: Deferred Tax Liabilities, Gross $4.62M; Deferred Tax Liabilities, Gross as first filed $4.38M.
- 2023-12-31: Deferred Tax Liabilities, Gross $4.99M.
- 2022-12-31: Deferred Tax Liabilities, Gross $4.79M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $5.45M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $4.62M 10-K · filed 2026-03-12 | $4.38M 10-K · filed 2025-03-06 |
| 2023-12-31 | $4.99M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $4.79M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $202.00K 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |